Shenzhen - Delayed Quote CNY
R&G PharmaStudies Co., Ltd. (301333.SZ)
44.46
+0.20
+(0.45%)
At close: April 28 at 3:04:49 PM GMT+8
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 1 |
| Avg. Estimate | -- | -- | 977M | 1.01B |
| Low Estimate | -- | -- | 885M | 1.01B |
| High Estimate | -- | -- | 1.07B | 1.01B |
| Year Ago Sales | -- | -- | 744M | 977M |
| Sales Growth (year/est) | -- | -- | 31.32% | 3.58% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 301333.SZ | -- | -- | -- | -- |
| S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Related Tickers
2181.HK Mabpharm Limited
0.455
0.00%
2509.HK Qyuns Therapeutics Co., Ltd.
11.200
+2.19%
9966.HK Alphamab Oncology
6.820
-1.30%
1672.HK ASCLETIS-B
6.180
-1.59%
RAPP Rapport Therapeutics, Inc.
11.38
+7.16%
REPL Replimune Group, Inc.
9.27
+2.43%
PULM Pulmatrix, Inc.
6.50
-1.90%
MDWD MediWound Ltd.
18.29
+1.16%
TVTX Travere Therapeutics, Inc.
19.36
+5.62%
2269.HK WuXi Biologics (Cayman) Inc.
23.500
+2.84%